Lilly Bamlanivimab Antibody Playbook

Lilly Bamlanivimab Antibody Playbook

This Antibody Playbook provides information for state, territorial and local public health programs.

This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.

Hand

Contact Us

For more information, connect with us.

(913) 262-1436

Related Content

A New Approach to Mitigate Drug Shortages

A 90-day pilot program provides pediatric hospitals with over 140,000 essential medicine treatments.

Sep. 15, 2022

Novel Low-Dose Syringe: Enhancing Pediatric Medication Safety

Children's hospitals identified a need for low-dose syringes and their collaboration led to the development of a safer option for medication administration in pediatric health care.

Sep. 14, 2022

The Facts About COVID-19 and Children

Read the latest data on kids' COVID-19 cases, hospitalizations and vaccination numbers.

Sep. 09, 2022